DAFNA CAPITAL MANAGEMENT LLC – KalVista Pharmaceuticals, Inc. Transaction History
DAFNA CAPITAL MANAGEMENT LLC portfolio value:
$3.70M
portfolio value
DAFNA CAPITAL MANAGEMENT LLC quarter portfolio value change:
+47.46%
quarter
KalVista Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -3.90% | -10.35K shares | 1.09M | $14.51 | 255.31K |
| Q2 2022 | share | Increase | +39.34% | 75K shares | -196K | $9.84 | 265.66K |
| Q1 2022 | share | 0.00% | 0 shares | 288K | $14.74 | 190.66K | |
| Q4 2021 | share | Increase | +0.79% | 1.5K shares | -779K | $13.58 | 190.66K |
| Q3 2021 | share | Increase | +212.15% | 128.56K shares | 1.84M | $17.45 | 189.16K |
| Q2 2021 | share | Increase | +3.41% | 2K shares | -53K | $23.96 | 60.6K |
| Q1 2021 | share | Increase | 0.00% | 58.6K shares | 1.50M | $25.69 | 58.6K |
| Q4 2020 | share | Decrease | -100.00% | -208.05K shares | -2.61M | $18.99 | 0 |
| Q3 2020 | share | Decrease | -6.47% | -14.39K shares | -73K | $12.59 | 208.05K |
| Q2 2020 | share | Decrease | -5.32% | -12.5K shares | 895K | $12.1 | 222.45K |
| Q1 2020 | share | Increase | +850.26% | 210.22K shares | 1.35M | $7.65 | 234.95K |
| Q4 2019 | share | 0.00% | 0 shares | 153K | $17.81 | 24.72K | |
| Q3 2019 | share | 0.00% | 0 shares | -261K | $11.6 | 24.72K | |
| Q2 2019 | share | Increase | +6.46% | 1.5K shares | -117K | $22.15 | 24.72K |
| Q1 2019 | share | Increase | +14.83% | 3K shares | 266K | $28.62 | 23.22K |
| Q4 2018 | share | Increase | +14.10% | 2.5K shares | 7K | $19.75 | 20.22K |
| Q3 2018 | share | Increase | 0.00% | 17.72K shares | 392K | $22.11 | 17.72K |